Stock PEXA B PEXA AB
Add to a list
To use this feature you must be a member
Log inSign up

Financials PExA AB

Equities

PEXA B

SE0007412374

Advanced Medical Equipment & Technology

End-of-day quote NORDIC GROWTH MARKET
Other stock markets
 18:00:00 2024-05-19 EDT 		5-day change 1st Jan Change
0.378 SEK -1.31% Intraday chart for PExA AB +1.61% -8.70%
02-21 PExA AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
02-21 PExA AB Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2017 2018 2019 2021 2022
Capitalization 1 35.52 27.59 20.67 49.97 27.23
Enterprise Value (EV) 1 22.66 19.43 18 29.26 8.976
P/E ratio -6.47 x -4.71 x -6.45 x -4.95 x -5.73 x
Yield - - - - -
Capitalization / Revenue 22 x 10.4 x 5.75 x 23.1 x 4.52 x
EV / Revenue 14 x 7.29 x 5.01 x 13.5 x 1.49 x
EV / EBITDA -4.18 x -3.36 x -3.03 x -3.91 x -2.31 x
EV / FCF -5.34 x -7.75 x -0.98 x -9.25 x -1.95 x
FCF Yield -18.7% -12.9% -102% -10.8% -51.3%
Price to Book 2.1 x 2.5 x 1.93 x 2.28 x 1.28 x
Nbr of stocks (in thousands) 9,226 9,226 9,226 34,704 42,276
Reference price 2 3.850 2.990 2.240 1.440 0.6440
Announcement Date 18-05-04 19-05-06 20-05-05 23-05-05 23-05-05
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2017 2018 2019 2021 2022
Net sales 1 1.618 2.665 3.593 2.161 6.027
EBITDA 1 -5.418 -5.788 -5.934 -7.476 -3.887
EBIT 1 -5.49 -5.871 -6.017 -7.799 -4.442
Operating Margin -339.39% -220.32% -167.47% -360.83% -73.7%
Earnings before Tax (EBT) 1 -5.491 -5.858 -6.007 -7.759 -4.305
Net income 1 -5.491 -5.858 -6.007 -7.759 -4.305
Net margin -339.41% -219.83% -167.2% -358.97% -71.43%
EPS 2 -0.5952 -0.6350 -0.3473 -0.2908 -0.1125
Free Cash Flow 1 -4.242 -2.508 -18.27 -3.162 -4.607
FCF margin -262.22% -94.12% -508.61% -146.28% -76.44%
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share - - - - -
Announcement Date 18-05-04 19-05-06 20-05-05 23-05-05 23-05-05
1SEK in Million2SEK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2017 2018 2019 2021 2022
Net Debt 1 - - - - -
Net Cash position 1 12.9 8.16 2.67 20.7 18.2
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow 1 -4.24 -2.51 -18.3 -3.16 -4.61
ROE (net income / shareholders' equity) -27.9% -41.9% -38.6% -45.5% -19.9%
ROA (Net income/ Total Assets) -15.5% -23.2% -21.6% -24.1% -10.8%
Assets 1 35.39 25.28 27.83 32.25 39.69
Book Value Per Share 2 1.830 1.200 1.160 0.6300 0.5000
Cash Flow per Share 2 1.390 0.8800 0.1500 0.6000 0.4300
Capex 1 0.04 - - 0.85 0.64
Capex / Sales 2.19% - - 39.46% 10.56%
Announcement Date 18-05-04 19-05-06 20-05-05 23-05-05 23-05-05
1SEK in Million2SEK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Medical Diagnostic & Testing Equipment

1st Jan change Capi.
PEXA AB Stock PExA AB
-8.70% 1.51M
SARTORIUS AG Stock Sartorius AG
-18.97% 18.12B
QUIDELORTHO CORPORATION Stock QuidelOrtho Corporation
-42.48% 2.87B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD. Stock Inner Mongolia Furui Medical Science Co., Ltd.
+22.69% 1.9B
SHANGHAI MICROPORT EP MEDTECH CO., LTD. Stock Shanghai MicroPort EP MedTech Co., Ltd.
-1.56% 1.65B
BIOTAGE AB Stock Biotage AB
+32.98% 1.34B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD. Stock Shanghai AoHua Photoelectricity Endoscope Co., Ltd.
-17.41% 957M
CONTEC MEDICAL SYSTEMS CO.,LTD Stock Contec Medical Systems Co.,Ltd
-22.25% 896M
REVENIO GROUP OYJ Stock Revenio Group Oyj
+10.31% 841M
VAREX IMAGING CORPORATION Stock Varex Imaging Corporation
-26.78% 612M
Medical Diagnostic & Testing Equipment
  1. Stock Market
  2. Equities
  3. PEXA B Stock
  4. Financials PExA AB
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW